December 2004
Generic Biotech
Biotech drugs can cost hundreds of thousands of dollars a year. Cheaper generic versions could save countless lives, but proving their safety and effectiveness is no easy task.
By Erika Jonietz
| Subscribe to the Technology Review Magazine
To view this article, you must have a paid subscription to Technology Review (print or digital edition) OR you can purchase credits to view individual articles. We have several options for content access:
Technology Review does more than tell you about what you can expect to see next. We explain it to you, in graphic, riveting detail. If it’s relevant to technology and the future, you’ll learn about it first in Technology Review. Well before the mainstream press wakes up to a technology breakthrough, Technology Review will have made it available to you. But we don’t just report—we analyze. You get in-depth coverage that’s authoritative, reliable, and universally respected.
|
|
|